MedPath

Exploratory Study for the Validity of QuQu Scale

Completed
Conditions
Alzheimer Dementia
Interventions
Other: Standard therapy of Alzheimer Dementia (AD)
Other: Observation
Registration Number
NCT02267486
Lead Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Brief Summary

Examine the construct validity, the group discriminant ability, and the inter-rater reliability of a novel dementia rating scale (QuQu scale: QUick QUestion scale) candidate for the evaluation of patients with Alzheimer Dementia (AD)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
972
Inclusion Criteria
  1. Alzheimer Dementia (AD) patients and patients with cognitive concern without dementia
  2. Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.
Exclusion Criteria
  1. patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia)
  2. patients with other diseases which cause secondary dementia prior to Alzheimer Dementia (AD)
  3. patients with other severe neurological disease or psychiatric disorder without Alzheimer Dementia (AD)
  4. patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Alzheimer Dementia (AD)Standard therapy of Alzheimer Dementia (AD)Patients with dementia caused by Alzheimer's disease
Non-dementiaObservationPatients with cognitive concern without dementia
Primary Outcome Measures
NameTimeMethod
Novel Dementia Rating Scale (QUick QUestion Scale)1 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kagawa University School of Medicine

🇯🇵

Kida-gun, Kagawa, Japan

© Copyright 2025. All Rights Reserved by MedPath